-
Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing
Post on 5/1/17
-
3 Key Things to Watch in Pfizer's Q1 Results
Post on 5/1/17
-
J&J Snack Foods: Index Funds Appear To Be Creating Overvaluation
Post on 5/1/17
-
Johnson & Johnson (JNJ) Investor Presentation - Slideshow
Post on 5/1/17
-
Merck's Daring Bid For Lung Cancer Domination
Post on 5/1/17
-
Celgene Corporation Earnings: Trading Price for Volume
Post on 5/1/17
-
3 Top Biotech Stocks to Buy Now
Post on 5/1/17
-
The 3 Best Pharmaceutical Stocks to Buy in 2017
Post on 5/1/17
-
Comcast (CMCSA) Q1 2017 Results - Earnings Call Transcript
Post on 4/28/17
-
Celgene (CELG) Q1 2017 Results - Earnings Call Transcript
Post on 4/28/17
-
GlaxoSmithKline Q1 2017: Mixed Signals For Investors
Post on 4/28/17
-
What's Happening With Johnson & Johnson's Pharmaceuticals Business?
Post on 4/28/17
-
Moberg Raises $3 Million
Post on 4/27/17
-
Mid-Atlantic Dental Partners Closes on 8th Practice at One Year Mark
Post on 4/27/17
-
LifeBridge Health Teams with Cognizant
Post on 4/27/17
-
MTBC Announces Signing of Two Key Healthcare Groups
Post on 4/27/17
-
Celgene Is A Must-Own Stock
Post on 4/27/17
-
Johnson & Johnson's Medical Device Business: What Investors Need to Know
Post on 4/27/17
-
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 4/26/17
-
PNC Financial Services (PNC) Investor Presentation - Slideshow
Post on 4/26/17
-
Teva Pharmaceutical: Negative In 2015, And Still Negative In 2017
Post on 4/26/17
-
3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb
Post on 4/26/17
-
J&J Snack Foods Corp's (JJSF) CEO Gerald Shreiber on Q2 2017 Results - Earnings Call Transcript
Post on 4/26/17
-
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Post on 4/26/17
-
Here's Why Risk-Averse Investors May Want to Think Twice About Buying Johnson & Johnson
Post on 4/26/17
Philadelphia
